DESEMPENHO DE FRANGOS DE CORTE, SEXADOS, SUBMETIDOS A DIETAS FORMULADAS PELOS CONCEITOS DE PROTEÍNA BRUTA versus PROTEÍNA IDEAL PERFORMANCE OF SEXED BROILER BIRDS, SUBMITTED TO DIETS FORMULATED BY THE CONCEPTS OF CRUDE PROTEIN versus IDEAL PROTEIN

O trabalho foi conduzido no Setor de Avicultura do Departamento de Zootecnia da Universidade Federal de Santa Maria com o objetivo de verificar as respostas de desempenho de frangos de corte, criados com sexos separados, alimentados pelo conceito tradicional (Proteína Bruta - PB) em comparação a dietas formuladas pelo critério de Proteína Ideal (PI), num período de 1 a 42 dias de idade. A análise econômica comparativa entre os dois métodos de alimentação também foi realizada. Foram utilizados 960 pintos de corte de um dia de idade (480 machos, 480 fêmeas) da linhagem ROSS. As dietas experimentais baseadas no conceito de PB foram formuladas segundo as recomendações do NRC (1994) e as dietas formuladas pelo conceito de PI foram adaptadas de HAN & BAKER (1994). O delineamento experimental foi o inteiramente casualizado, constituindo 4 tratamentos com 12 repetições de 20 aves cada. Foram estudados os parâmetros: consumo alimentar, ganho de peso e peso corporal, ganho médio diário, conversão alimentar e índice de eficiência nutricional. Os resultados obtidos indicaram que os parâmetros estudados foram mais influenciados na fase inicial. As dietas formuladas pelo conceito de PI, baseada no conteúdo de aminoácidos digestíveis (AAD), influenciaram positivamente os parâmetros estudados, proporcionando significativos melhores ganhos de peso e eficiência alimentar, tanto para os machos quanto para as fêmeas nas fases inicial e total, sendo similares nas demais fases. As aves alimentadas com AAD apresentaram uma maior lucratividade nas fases inicial e crescimento. Esses dados permitem concluir que dietas à base de milho e farelo de soja, formuladas para atender às exigências de AAD, proporcionam melhores desempenhos biológico e econômico, em relação àquelas formuladas à base de PB, do primeiro até os 35 dias de idade. A fase final mostrou o contrário, sendo o conceito de PB mais econômico do que a Pl.The study was carried out at the Poultry Section of the Departament of Animal Science at Federal University of Santa Maria, in order to evaluate the performance of broilers grown sexed and fed with diets formulated by the traditional concept (Crude Protein - CP), which is based on total amimo acids (TAA) and fed with the approach of Ideal Protein (IP), which is based on digestible amino acids (DAA), in the period from 1 to 42 days of age. A comparative economic analysis among the two feeding methods was also accomplished. There were 960 chicks (Ross) at the age of 1 day, being 480 males and 480 females. The diet based on the concept of CP was formulated according to the recommendation of NRC (1994) and the diet formulated by the concept of IP was adapted from Han and Baker (1994). The completely randomized experimental design consisted of 4 treatments with 12 replications of 20 chicks each. The feed intake, phase gain, body weight, daily gain, feed conversion and the nutritional efficieny index were evaluated. The results indicated that the parameters studied were more efficient in the initial phase. The diet formulated by the Ideal Protein concept, based on the content of DAA, influenced all parameters studied positively, providing significantly better gain weight and feed efficiency in both male and female chicks in the initial and final phases, being similar in the growing phase. The chicks fed with DAA showed greater profits in the initial phase and during the growth phase. These data allowed the conclusion that diets containing corn and soybean meal as base for the formulated feed provides better biological and economic performance of the broilers when compared to those formulated with crude Protein, from day the first up to 35 days of age. The final phase (35-42) showed the contrary, being the CP concept more economical than IP

Organização supramolecular da ftalocianina de cobalto(II) e seu efeito na oxidação do aminoácido cisteína Supramolecular organization of cobalt (II) phthalocyanine on the pathway of cysteine oxidation

<abstract language="eng">The interest in the chemistry of cobalt (II) tetrasulfonated phthalocyanine (PcTsCo) comes mainly from its macrocycle-ligand structure combined with their special chemical characteristics, such as high solubility, well-defined redox reactions and remarkable optical absorption in the visible region. In this work, we use layer-by-layer technique in order to assemble CoTsPc and poly(allylaminehydrochloride) (PAH) in hybrid supramolecular system. The electronic spectroscopy and cyclic voltammetry techniques were utilized to study PAH/CoTsPc multilayers growth and the cysteine catalytic oxidation. PAH/CoTsPc showed high electrochemical stability and worthwhile to mention is the remarkable influence of supramolecular arrangement on the final redox properties of the system

Characterisation of microbial attack on archaeological bone

As part of an EU funded project to investigate the factors influencing bone preservation in the archaeological record, more than 250 bones from 41 archaeological sites in five countries spanning four climatic regions were studied for diagenetic alteration. Sites were selected to cover a range of environmental conditions and archaeological contexts. Microscopic and physical (mercury intrusion porosimetry) analyses of these bones revealed that the majority (68%) had suffered microbial attack. Furthermore, significant differences were found between animal and human bone in both the state of preservation and the type of microbial attack present. These differences in preservation might result from differences in early taphonomy of the bones. © 2003 Elsevier Science Ltd. All rights reserved

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI) : a phase 3, placebo-controlled, randomised trial

Background: Patients with stable coronary artery disease and diabetes with previous percutaneous coronary intervention (PCI), particularly those with previous stenting, are at high risk of ischaemic events. These patients are generally treated with aspirin. In this trial, we aimed to investigate if these patients would benefit from treatment with aspirin plus ticagrelor. Methods: The Effect of Ticagrelor on Health Outcomes in diabEtes Mellitus patients Intervention Study (THEMIS) was a phase 3 randomised, double-blinded, placebo-controlled trial, done in 1315 sites in 42 countries. Patients were eligible if 50 years or older, with type 2 diabetes, receiving anti-hyperglycaemic drugs for at least 6 months, with stable coronary artery disease, and one of three other mutually non-exclusive criteria: a history of previous PCI or of coronary artery bypass grafting, or documentation of angiographic stenosis of 50% or more in at least one coronary artery. Eligible patients were randomly assigned (1:1) to either ticagrelor or placebo, by use of an interactive voice-response or web-response system. The THEMIS-PCI trial comprised a prespecified subgroup of patients with previous PCI. The primary efficacy outcome was a composite of cardiovascular death, myocardial infarction, or stroke (measured in the intention-to-treat population). Findings: Between Feb 17, 2014, and May 24, 2016, 11 154 patients (58% of the overall THEMIS trial) with a history of previous PCI were enrolled in the THEMIS-PCI trial. Median follow-up was 3·3 years (IQR 2·8–3·8). In the previous PCI group, fewer patients receiving ticagrelor had a primary efficacy outcome event than in the placebo group (404 [7·3%] of 5558 vs 480 [8·6%] of 5596; HR 0·85 [95% CI 0·74–0·97], p=0·013). The same effect was not observed in patients without PCI (p=0·76, p interaction=0·16). The proportion of patients with cardiovascular death was similar in both treatment groups (174 [3·1%] with ticagrelor vs 183 (3·3%) with placebo; HR 0·96 [95% CI 0·78–1·18], p=0·68), as well as all-cause death (282 [5·1%] vs 323 [5·8%]; 0·88 [0·75–1·03], p=0·11). TIMI major bleeding occurred in 111 (2·0%) of 5536 patients receiving ticagrelor and 62 (1·1%) of 5564 patients receiving placebo (HR 2·03 [95% CI 1·48–2·76], p<0·0001), and fatal bleeding in 6 (0·1%) of 5536 patients with ticagrelor and 6 (0·1%) of 5564 with placebo (1·13 [0·36–3·50], p=0·83). Intracranial haemorrhage occurred in 33 (0·6%) and 31 (0·6%) patients (1·21 [0·74–1·97], p=0·45). Ticagrelor improved net clinical benefit: 519/5558 (9·3%) versus 617/5596 (11·0%), HR=0·85, 95% CI 0·75–0·95, p=0·005, in contrast to patients without PCI where it did not, p interaction=0·012. Benefit was present irrespective of time from most recent PCI. Interpretation: In patients with diabetes, stable coronary artery disease, and previous PCI, ticagrelor added to aspirin reduced cardiovascular death, myocardial infarction, and stroke, although with increased major bleeding. In that large, easily identified population, ticagrelor provided a favourable net clinical benefit (more than in patients without history of PCI). This effect shows that long-term therapy with ticagrelor in addition to aspirin should be considered in patients with diabetes and a history of PCI who have tolerated antiplatelet therapy, have high ischaemic risk, and low bleeding risk

Effects of pre-operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study an international prospective cohort study

We aimed to determine the impact of pre-operative isolation on postoperative pulmonary complications after elective surgery during the global SARS-CoV-2 pandemic. We performed an international prospective cohort study including patients undergoing elective surgery in October 2020. Isolation was defined as the period before surgery during which patients did not leave their house or receive visitors from outside their household. The primary outcome was postoperative pulmonary complications, adjusted in multivariable models for measured confounders. Pre-defined sub-group analyses were performed for the primary outcome. A total of 96,454 patients from 114 countries were included and overall, 26,948 (27.9%) patients isolated before surgery. Postoperative pulmonary complications were recorded in 1947 (2.0%) patients of which 227 (11.7%) were associated with SARS-CoV-2 infection. Patients who isolated pre-operatively were older, had more respiratory comorbidities and were more commonly from areas of high SARS-CoV-2 incidence and high-income countries. Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0%, respectively), isolation was associated with higher rates of postoperative pulmonary complications after adjustment (adjusted OR 1.20, 95%CI 1.05–1.36, p = 0.005). Sensitivity analyses revealed no further differences when patients were categorised by: pre-operative testing; use of COVID-19-free pathways; or community SARS-CoV-2 prevalence. The rate of postoperative pulmonary complications increased with periods of isolation longer than 3 days, with an OR (95%CI) at 4–7 days or ≥ 8 days of 1.25 (1.04–1.48), p = 0.015 and 1.31 (1.11–1.55), p = 0.001, respectively. Isolation before elective surgery might be associated with a small but clinically important increased risk of postoperative pulmonary complications. Longer periods of isolation showed no reduction in the risk of postoperative pulmonary complications. These findings have significant implications for global provision of elective surgical care. We aimed to determine the impact of pre-operative isolation on postoperative pulmonary complications after elective surgery during the global SARS-CoV-2 pandemic. We performed an international prospective cohort study including patients undergoing elective surgery in October 2020. Isolation was defined as the period before surgery during which patients did not leave their house or receive visitors from outside their household. The primary outcome was postoperative pulmonary complications, adjusted in multivariable models for measured confounders. Pre-defined sub-group analyses were performed for the primary outcome. A total of 96,454 patients from 114 countries were included and overall, 26,948 (27.9%) patients isolated before surgery. Postoperative pulmonary complications were recorded in 1947 (2.0%) patients of which 227 (11.7%) were associated with SARS-CoV-2 infection. Patients who isolated pre-operatively were older, had more respiratory comorbidities and were more commonly from areas of high SARS-CoV-2 incidence and high-income countries. Although the overall rates of postoperative pulmonary complications were similar in those that isolated and those that did not (2.1% vs 2.0%, respectively), isolation was associated with higher rates of postoperative pulmonary complications after adjustment (adjusted OR 1.20, 95%CI 1.05–1.36, p = 0.005). Sensitivity analyses revealed no further differences when patients were categorised by: pre-operative testing; use of COVID-19-free pathways; or community SARS-CoV-2 prevalence. The rate of postoperative pulmonary complications increased with periods of isolation longer than 3 days, with an OR (95%CI) at 4–7 days or ≥ 8 days of 1.25 (1.04–1.48), p = 0.015 and 1.31 (1.11–1.55), p = 0.001, respectively. Isolation before elective surgery might be associated with a small but clinically important increased risk of postoperative pulmonary complications. Longer periods of isolation showed no reduction in the risk of postoperative pulmonary complications. These findings have significant implications for global provision of elective surgical care